Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $155506.0.

  • iSpecimen's Current Deferred Revenue fell 4516.15% to $155506.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $155506.0, marking a year-over-year decrease of 4516.15%. This contributed to the annual value of $360708.0 for FY2024, which is 1324.36% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Current Deferred Revenue is $155506.0, which was down 4516.15% from $164066.0 recorded in Q2 2025.
  • iSpecimen's Current Deferred Revenue's 5-year high stood at $802860.0 during Q2 2021, with a 5-year trough of $46910.0 in Q3 2023.
  • For the 5-year period, iSpecimen's Current Deferred Revenue averaged around $330971.4, with its median value being $272681.0 (2024).
  • As far as peak fluctuations go, iSpecimen's Current Deferred Revenue crashed by 8278.66% in 2023, and later surged by 50450.01% in 2024.
  • iSpecimen's Current Deferred Revenue (Quarter) stood at $654746.0 in 2021, then crashed by 79.79% to $132335.0 in 2022, then skyrocketed by 214.18% to $415771.0 in 2023, then decreased by 13.24% to $360708.0 in 2024, then tumbled by 56.89% to $155506.0 in 2025.
  • Its last three reported values are $155506.0 in Q3 2025, $164066.0 for Q2 2025, and $270208.0 during Q1 2025.